Exagen Inc. (XGN)
NASDAQ · Healthcare
Exagen Inc. Long Term Debt 2018–2025
Exagen Inc. annual long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Exagen Inc. long term debt as of December 31, 2025: 22.9M, a 13.15% increase year-over-year.
- Exagen Inc. long term debt for 2025 were 22.9M, a 13.15% increase from 2024.
- Exagen Inc. long term debt for 2024 were 20.2M, a 3.85% increase from 2023.
- Exagen Inc. long term debt for 2023 were 19.5M, a 32.70% decrease from 2022.
- Exagen Inc. long term debt for 2022 were 29.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Exagen Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $23 |
| 2024 | $20 |
| 2023 | $19 |
| 2022 | $29 |
| 2021 | $27 |
| 2020 | $27 |
| 2019 | $26 |
| 2018 | $25 |
Exagen Inc. Long Term Debt — FAQ
Exagen Inc. (XGN) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XGN's long term debt history?
The chart and table above show Exagen Inc.'s long term debt by year and by quarter, including the growth rate.